Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial
Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedSponsor and collaborators information, along with expanded MeSH terms and keywords, have been added to the study record to improve attribution and searchability. The changes also incorporate references like Plan for IPD and related terminology to better describe the study and its context.SummaryDifference69%

- Check16 days agoChange DetectedThe page revision has been updated to v3.6.5, replacing v3.6.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check23 days agoChange DetectedNo changes were recorded in the provided data; the page content remains as previously captured.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4. This reflects a small refresh of the page without changes to the study data.SummaryDifference0.1%

- Check45 days agoChange DetectedNo textual changes were reported for the page; the content remains the same as the previous version.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision tag shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a software/deployment update and does not alter visible content.SummaryDifference0.0%

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.